Table 2 |
|||||
|
Characteristics of the diet consumed at baseline and 12 weeks, by group |
|||||
|
RSV+Fib |
RSV |
SIM/EZE+Fib |
SIM+EZE |
P-value |
|
|
N = 28 |
N = 30 |
N = 28 |
n = 30 |
||
|
|
|||||
|
MUFA%1 |
|||||
|
Baseline |
13.8 (0.7) |
12.8 (0.7) |
13.4 (1.0) |
11.8 (0.7) |
0.374 |
|
12 weeks |
12.9 (0.6) |
13.6 (0.8) |
13.4 (0.5) |
11.5 (0.6) |
0.094 |
|
PUFA%1 |
|||||
|
Baseline |
9.1 (0.6) |
11.9 (1.0) |
10.3 (0.8) |
10.3 (1.0) |
0.329 |
|
12 weeks |
8.3 (0.8) |
10.7 (1.1) |
9.6 (0.6) |
8.2 (0.7) |
0.098 |
|
SAFA%1 |
|||||
|
Baseline |
9.7 (0.6) |
9.5 (0.6) |
9.5 (0.5) |
9.1 (0.6) |
0.833 |
|
12 weeks |
9.3 (0.5) |
9.4 (0.5) |
9.5 (0.7) |
8.9 (0.7) |
0.717 |
|
Trans FA%1 |
|||||
|
Baseline |
0.3 (0.1) |
0.4 (0.1) |
0.3 (0.1) |
0.3 (0.1) |
0.608 |
|
12 weeks |
0.3 (0.1) |
0.4 (0.1) |
0.4 (0.2) |
0.4 (0.1) |
0.237 |
|
Energy Kcal/day2 |
|||||
|
Baseline |
1762 (116) |
1766 (100) |
1828 (156) |
1741 (136) |
0.001a |
|
12 weeks |
1653 (116) |
1520 (85) |
1585 (129) |
1599 (102) |
0.990b |
|
Lipids%1 |
|||||
|
Baseline |
36.1 (1.4) |
37.3 (1.9) |
36.3 (1.7) |
34.3 (1.8) |
0.941 |
|
12 weeks |
33.9 (1.4) |
36.9 (1.8) |
35.7 (1.2) |
31.4 (1.6) |
0.041 |
|
Carbohydrates%1 |
|||||
|
Baseline |
46.4 (1.9) |
46.9 (2.1) |
46.7 (2.3) |
49.2 (2.1) |
0.869 |
|
12 weeks |
46.3 (1.5) |
46.5 (1.6) |
46.7 (1.7) |
52.1 (1.8) |
0.034 |
|
Proteins%1 |
|||||
|
Baseline |
18 (1.3) |
16.5 (1.0) |
17.7 (1.3) |
17.3 (0.9) |
0.79 |
|
12 weeks |
20 (1.0) |
17.6 (0.9) |
18.5 (1.2) |
17.8 (0.8) |
0.268 |
|
Cholesterol mg/day2 |
|||||
|
Baseline |
214 (29) |
200 (21) |
197 (33) |
210 (29) |
0.203a |
|
12 weeks |
222 (29) |
157 (12) |
201 (34) |
171 (22) |
0.683b |
|
Fibers g/day2 |
|||||
|
Baseline |
20 (3) |
17 (1) |
22 (3) |
16 (2) |
0.853a |
|
12 weeks |
20 (2) |
16 (1) |
18 (2) |
19 (2) |
0.666a |
|
|
|||||
|
Differences analyzed by Kruskal-Wallis test1 or General Linear Model-repeated measures followed by Tukey's test2, with p-values for comparisons abetween visits and bbetween groups. MUFA = monounsaturated fatty acids; PUFA = polyunsaturated fatty acids; SAFA = saturated fatty acids; RSV = rosuvastatin 40 mg; Fib = fiber; SIM = simvastatin 40 mg; EZE = ezetimibe 10 mg; FA = fatty acids. |
|||||
|
Ramos et al. Nutrition Journal 2011 10:80 doi:10.1186/1475-2891-10-80 |
|||||
